Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) EBIT Margin (2022 - 2025)

Core Laboratories' EBIT Margin history spans 4 years, with the latest figure at 22.42% for Q4 2025.

  • For Q4 2025, EBIT Margin fell 3339.0% year-over-year to 22.42%; the TTM value through Dec 2025 reached 1.83%, down 935.0%, while the annual FY2025 figure was 1.83%, 935.0% down from the prior year.
  • EBIT Margin reached 22.42% in Q4 2025 per CLB's latest filing, down from 15.56% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 15.56% in Q3 2025 to a low of 22.42% in Q4 2025.
  • Average EBIT Margin over 4 years is 8.63%, with a median of 11.63% recorded in 2022.
  • Peak YoY movement for EBIT Margin: surged 515bps in 2023, then plummeted -3339bps in 2025.
  • A 4-year view of EBIT Margin shows it stood at 12.24% in 2022, then dropped by -7bps to 11.37% in 2023, then dropped by -4bps to 10.97% in 2024, then tumbled by -304bps to 22.42% in 2025.
  • Per Business Quant, the three most recent readings for CLB's EBIT Margin are 22.42% (Q4 2025), 15.56% (Q3 2025), and 11.75% (Q2 2025).